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Preamble 
This consensus paper provides a framework for grading of severity of cardiovascular magnetic 
resonance (CMR) imaging-based assessment of chamber size, function and aortic 
measurements. This does not currently exist for CMR measures. Differences exist in the normal 
reference values between echocardiography and CMR along with differences in methods used to 
derive these. We feel that this document will significantly complement the current literature and 
provide a practical guide for clinicians in daily reporting and interpretation of CMR scans. 
 
This manuscript aims to complement a recent comprehensive review of CMR normal value 
publications to recommend cut-off values required for severity grading. Standardization of 
severity grading for clinically useful CMR parameters is encouraged to lead to clearer and easier 
communication with referring clinicians and may contribute to better patient care. To this end, 
the European Association of Cardiovascular Imaging (EACVI) has formed this expert panel that 
has critically reviewed the literature and has come to a consensus on approaches to severity 
grading for commonly quantified CMR parameters. 
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 51 
Preamble 52 
This consensus paper provides a framework for grading of severity of cardiovascular magnetic 53 
resonance (CMR) imaging-based assessment of chamber size, function and aortic measurements. 54 
This does not currently exist for CMR measures. Differences exist in the normal reference values 55 
between echocardiography and CMR along with differences in methods used to derive these. We 56 
feel that this document will significantly complement the current literature and provide a practical 57 
guide for clinicians in daily reporting and interpretation of CMR scans. 58 
 59 
This manuscript aims to complement a recent comprehensive review of CMR normal value 60 
publications to recommend cut-off values required for severity grading. Standardization of 61 
severity grading for clinically useful CMR parameters is encouraged to lead to clearer and easier 62 
communication with referring clinicians and may contribute to better patient care. To this end, the 63 
European Association of Cardiovascular Imaging (EACVI) has formed this expert panel that has 64 
critically reviewed the literature and has come to a consensus on approaches to severity grading 65 
for commonly quantified CMR parameters. 66 
 67 
 68 
 69 
 70 
 71 
 72 
 73 
 74 
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Introduction 76 
Cardiovascular Magnetic Resonance (CMR) imaging is now firmly established in clinical practice as 77 
a cardiac imaging modality, which complements other non-invasive techniques, such as 78 
echocardiography, nuclear cardiac imaging and cardiac computed tomography. CMR has an 79 
important role in a wide range of clinical indications and scenarios.1-3 80 
 81 
Patient impact is dependent on the quality of the clinical CMR service provision. Efforts to 82 
standardize CMR image acquisition,4,5 CMR image analysis and CMR image reporting contribute to 83 
raising overall CMR service quality.6 Certification of individuals in CMR sets minimum standards of 84 
expertise and provides evidence to those that can demonstrate it.7 85 
 86 
Communication of CMR and other imaging modality findings is a key component to ensure that 87 
they positively impact patient management.8 Complementing a description of a parameter as 88 
being normal or abnormal (reference values), clinical imaging physicians most often qualify the 89 
extent of abnormalities using terms such as ‘mild’, ‘moderate’ or ‘severe’. Such descriptions allow 90 
the clinician not only to understand that the parameter is abnormal but also the extent to which 91 
their patient’s measurements deviate from normal. As well as providing normative data it would 92 
be beneficial to standardize cut-offs for severity of abnormality across centres, such that 93 
moderately abnormal has the same implication in all. The association of continuous information 94 
with prognosis may be stronger than between the categories of normal, mildly, moderately and 95 
severely abnormal and prognosis.9 However, communication of the degree of abnormality in 96 
categories may be clearer to the referring physician and thus may lead to more rapid and 97 
consistent clinical decisions.  98 
 99 
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For CMR measurements there is no consensus on how to categorize the severity of abnormality. 100 
The echocardiography community has published consensus statements to this end.10,11 Here, we 101 
attempt to suggest approaches to grade the severity of abnormality for common and clinically 102 
useful CMR parameters. Recommendations on image analysis, including chamber quantification, 103 
have been published and are not the scope of this paper.6 Readers of this expert consensus article 104 
should ensure they are aware of the analysis methods used for the original data from which the 105 
normal reference ranges are derived, as different analysis approaches can have a clinically 106 
relevant impact on results. Between CMR and other imaging modalities that can measure the 107 
same phenotype systemic biases may exist. Using the same cut-off values based on different 108 
modalities may thus not always be appropriate and even using the same cut-off values for 109 
different CMR techniques needs to be interpreted with caution given documented differences 110 
(e.g. between fast gradient echo and steady state free procession for myocardial mass and 111 
volumes).12 112 
The authors acknowledge explicitly that the same value on a continuous scale or the same 113 
category may not reflect the same degree of abnormality depending on the context. Despite a 114 
normal left ventricular ejection fraction value in the context of severe mitral regurgitation this may 115 
still suggest an abnormal systolic function. Similarly, a patient with severe concentric hypertrophy 116 
and a ‘normal’ left ventricular ejection fraction may still have abnormal systolic function. Thus, any 117 
attempt to categorize the severity of abnormality should not be seen as providing optimal cut-off 118 
values in every case. Physicians reporting CMR scans should provide an interpretation that 119 
considers the clinical context. 120 
 121 
  122 
 6 
Methodology for severity grading 123 
 124 
The writing group considered several different approaches to define the cut-off values for mild, 125 
moderate and severely abnormal measurements. Multiple statistical techniques exist for 126 
determining threshold values, all of which have limitations.13 The first approach would be to 127 
define these cut-offs for abnormalities based on standard deviations below and above the normal 128 
reference limit derived from a group of healthy subjects. These data exist for most CMR 129 
parameters. However, not all cardiac parameters are normally distributed, such as aortic valve 130 
regurgitant fraction, making the use of standard deviation as a measure of spread potentially 131 
problematic. 132 
The second approach would be to define abnormalities based on percentile values (95th, 99th, 133 
etc.) of measurements. These are derived from a population that would include normal subjects 134 
along with individuals with disease states.14 They would consider asymmetric distribution and 135 
range of abnormality present within the general population. A limiting factor for this approach is 136 
that large enough population data sets do not exist for most CMR variables. Ideally, an approach 137 
could classify outcomes directly. A moderately abnormal variable would imply a moderate risk of a 138 
particular adverse outcome for that patient. Risk data are still sparse for some CMR measures and 139 
a moderate degree of deviation from normal may have differential effects on different important 140 
outcomes (e.g. morbidity and mortality). The third approach defines cut-off values based on 141 
expert opinion. Although scientifically least rigorous, this method considers the collective 142 
experience of a panel of experienced CMR experts. We used expert consensus mainly when the 143 
statistical methods would not provide equally distributed value ranges between the severity 144 
categories and to provide some consistency if well-established cut-offs exist for other imaging 145 
modalities (e.g. LVEF grading). Despite the limitations, this categorization of CMR parameters in 146 
the abnormal range represents another step towards the standardization of clinical CMR 147 
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complementing the consensus documents on CMR image acquisition, interpretation and analysis 148 
and reporting.4,6,15 Derived parameter values could be automatically categorized in clinical 149 
reporting software or in clinical trials for improved interpretation of CMR results. 150 
 151 
In the following sections we present consensus suggestions on the grading severity of abnormality 152 
based on the anatomical structure assessed. We do not attempt to provide values for each normal 153 
reference paper that exists at the time of publication. Specifically, this consensus paper 154 
complements a comprehensive recent systematic review of normal ranges using CMR.16 Much of 155 
what is presented in this paper is derived from published normal ranges with relatively small 156 
samples but can be updated in the future, using the same principles, with larger datasets. For 157 
example, it would also be ideal to have reference ranges categorized by age as well as gender. 158 
However, because of the small number of individuals included in the current studies, the 159 
consensus was to delay providing age categorised grading until larger reference ranges are 160 
published. This will hopefully provide more accurate ranges. We did not include the recent UK 161 
Biobank reference ranges in this consensus document given that the LV ejection fractions were 162 
significantly lower than currently accepted normal ranges.17 Further analysis of the data was 163 
considered to be required by the writing group before recommending its use in routine clinical 164 
practice. It should also be noted that recent European Society of Cardiology heart failure 165 
guidelines now categorise heart failure patients as those having reduced (<40%), mid-range (40-166 
49%) and preserved (>50%) ejection fraction based on transthoracic echocardiographic 167 
measures.18 168 
 169 
Most of the normal range publications did not specify the ethnicity but were derived from a 170 
Western population and would largely if not all have been Caucasians and predominantly from the 171 
United Kingdom.19-25 The approaches here are mostly defining cut-off values based on standard 172 
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deviations reported in the normal population apart from ejection fraction measurement that are 173 
derived from a combination of standard deviation and expert consensus.  Using the statistical 174 
method, the normal range is defined as +/- 2 standard deviations from the mean, mildly abnormal 175 
from this cut-off to 3 SD, moderately abnormal from the mild cut-off to 4 SD and severe being 176 
more than 4 SD from the population mean.  The term “Opposite” refers to values that are outside 177 
the normal range but in the opposite direction of typical thought of as pathology, e.g. smaller LV 178 
end-diastolic volumes or supra-normal LV ejection fraction. This consensus agreement was to 179 
allow commonly used cut-offs that are used for different imaging modalities and avoid confusion. 180 
It should be emphasized that these cut-offs are to allow clearer and easier communication of 181 
grading. As such, any new or omitted reference range can easily be categorized using the same 182 
principles. 183 
 184 
Measurements and methods 185 
 186 
The summary of measurements and techniques used in deriving the normal values from the 187 
published papers that are included in this consensus paper are included in Table 1 with description 188 
of the methodology used in the relevant subsections. Table 2 provided additional details of the 189 
individual studies used to derive the grading parameters.  Grading suggestions for left ventricular 190 
(Table 3), right ventricular (Table 4), left atrial (Table 5), right atrial (Table 6) and aortic parameters 191 
(Table 7), based mainly on a recent review containing normal ranges, are provided.16  192 
 193 
Left and right ventricular ejection fraction 194 
Ejection fraction of the left ventricle is one of the most commonly used cardiac imaging 195 
parameters in clinical practice. Left and right ventricular ejection fraction grades were decided on 196 
using a combination of statistical method and consensus consistent with the method used by the 197 
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EACVI echocardiography recommendations.11 Normal range was based on statistical method 198 
(published mean +/- 2 standard deviation). Mildly reduced systolic function was based on a 199 
combination of statistical method (for upper range, mean - 2 standard deviations) and consensus 200 
(for lower range). Grading for moderate and severely reduced left ventricular systolic function was 201 
based on consensus between the group and in line with the cut offs published in the EACVI 202 
echocardiography document.11  203 
Normalizing or indexing the reference values according to body habitus can be done in many 204 
different ways, most commonly values are indexed to body surface area. The principles of 205 
categorizing abnormal values to mildly, moderately or severely abnormal are independent of the 206 
indexing approach. 207 
 208 
Left and right atria  237 
 238 
We would ideally recommend using volume assessment rather than the areas for the atria for 239 
increased accuracy. However, there are some discrepancies in the normal reference values for LA 240 
volume between some studies and this should be considered when interpreting the results.19,21 As 241 
3-dimensional analysis tools are not readily available and may be more time consuming, our 242 
current recommendation would be to use the biplane method of disks/ area analysis based on 2-243 
dimensional images from 4 and 2 chamber views.  There is need for a future update of the grading 244 
cut-offs for LA and RA volumes with larger reference range studies. In the meantime, we have still 245 
included the LA area measurements. Similar caution in interpretation should be used when 246 
assessing RA volume measurements as discrepancies also exist for normal reference range values 247 
for the RA. This is likely in part due to the assumptions made when using the equations to derive 248 
volume measurements from a single 4 chamber view.  249 
 250 
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It should be noted that echo assessment predominantly uses the area-length method or the 251 
modified Simpson’ rule (Figure 2). Differences in volumes from 3D CMR measures and from echo 252 
will exist due to different techniques, spatial resolution and from the inclusion of the appendages 253 
in the volumes measured by CMR. For these reasons care should be taken to avoid direct 254 
comparison of measurements and cut-offs obtained from CMR and echo. 255 
 256 
Aortic root indices  257 
Although the proposed acquisition method is relatively simple, correct alignment of the oblique 258 
sagittal and coronal imaging planes may be difficult and ensuring reliable measurements can be 259 
challenging, as applied in the study of Burman et al.25 A 3-dimensional SSFP or a contrast enhanced 260 
magnetic resonance angiography may be the more appropriate method for ensuring precise 261 
measurements. However, further studies are needed to validate the most accurate and 262 
reproducible method of measuring the aorta using CMR and other imaging modalities. Previous 263 
guidelines recommended that maximum aneurysm diameter be ideally measured perpendicular to 264 
the centre line of the vessel with 3-dimensional reconstruction of CT scan images whenever 265 
possible. This approach appears to offer more accurate and reproducible measurements of true 266 
aortic dimensions compared with axial cross-section diameters. Using sagittal and coronal views in 267 
CMR can provide a good estimation of aortic measurements but may be inaccurate in measuring 268 
the true maximum diameters in cases where asymmetry exists. 269 
 270 
Limitations 271 
 272 
 273 
The measures for grading are based on currently available normal ranges. These are based on 274 
relatively small cohorts of healthy volunteers and there may be some variations between 275 
published reference ranges. Utilizing the methodology outlined in this consensus paper we plan to 276 
update this consensus paper using normal ranges of larger cohorts, such as from the UK Biobank 277 
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study, once further validation work has been completed in order to provide more robust reference 278 
ranges. Reference values for LV volumes and mass are influenced by gender and age and thus 279 
were presented separately in reference range paper, however, given the small sample sizes in the 280 
age categorized tables we considered it would be more accurate to provide age categorized 281 
grading parameters derived from larger data sets in the future. 282 
Indexed measurements may present limitations when considering obese patients, as the increase 283 
in chambers volumes/dimensions is not necessarily proportional to the increase in body surface 284 
area and may thus lead to inconsistencies. Unfortunately, this is a common problem for a number 285 
of imaging modalities and is not unique to CMR. Ideally the cut-offs for severity categorization 286 
using CMR and other imaging modalities should be linked with their impact on the outcomes. 287 
However, data regarding this are currently limited. Direct comparison in large cohorts with 288 
echocardiography should be done in the future since CMR and echo measures are not directly 289 
comparable (different techniques, different measurements’ methods) and cut-offs may not be the 290 
same when considering severity categorization. This will have obvious clinical impact such as when 291 
deciding on suitability for advanced cardiac device therapy e.g. cardiac resynchronization therapy 292 
or implantable cardioverter defibrillators.  293 
 294 
Aortic measurements may be more accurately determined using more advanced CMR techniques 295 
(e.g. 3D high resolution non-contrast native MRA with high isotropic resolution); also, the studies 296 
quoted were published before the SCMR 2013 Standardized image interpretation and post 297 
processing in CMR paper,6 so could introduce some variability in measurements reported between 298 
the studies quoted, and contemporary practices. 299 
 300 
The normal ranges for right ventricular end-diastolic volumes indexed to body surface area using 301 
the contemporary steady state free precession cine imaging approach contain the cut-off values 302 
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for major or minor criteria as part of the ARVC task force criteria.26 The ARVC task force criteria 303 
were developed largely based on gradient echo cine CMR which is known to underestimate 304 
volumes due to lower/incomplete endocardial border definition.12,27 Arguably, the ARVC Task 305 
Force criteria may need updating based on contemporary SSFP cine normal ranges provided in this 306 
expert consensus document to avoid being too sensitive or lacking specificity. 307 
 308 
  309 
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Table 1: Summary of measurements and techniques used in the normal values published papers included in this 431 
consensus paper. 432 
Parameter/Method Technique Advantages Limitations 
LV mass and volumes19,20  
(Figure 1) 
Papillary muscles included in 
the mass and excluded from 
the volumes (Figure 1) 
More accurate 
assessment of mass 
More time consuming. 
Often not followed in 
clinical practice 
RV mass and volumes19,20 
(Figure 1) 
Papillary muscles included in 
the mass and excluded from 
the volumes (Figure 1) 
More accurate 
assessment of mass 
More time consuming  
LA volumes19 
(Figure 2) 
Biplane area-length method 
in HLA and VLA. LA 
appendage included in LA 
area but not PVs (Figure 2) 
Available from 
standard imaging 
SSFP 
Not as accurate as SAX 
contours or 3D analysis 
LA volumes21 3D modelling, including 
tracking of AV ring. At phase 
in which LA size maximal. LA 
appendage included in LA 
area but not PVs 
More accurate than 
biplane area length 
method 
Requires 3D modelling 
software for SSFP image 
analysis 
RA volumes22 
(Figure 3) 
3D modelling, including 
tracking of AV ring and time 
volume curves. At phase in 
which RA size maximal. 
More accurate than 
area length method 
(Figure 3) 
Requires 3D modelling 
software for SSFP image 
analysis 
Aortic root dimensions25 
(Figure 4) 
SSFP images endo-endo from 
oblique coronal and oblique 
sagittal views in late diastole 
(Figure 4) 
Accurate assessment 
of aortic dimensions 
in 2D 
Requires ECG gating. Not 
as accurate as 3D 
assessment 
 433 
Abbreviations: AV= Atrioventricular; HLA= Horizontal long axis; LA= Left atrium; LV= Left ventricle; 434 
PV= Pulmonary vein; RA= Right atrium; RV= Right ventricle; SAX= Short axis; SSFP= Steady state 435 
free precession; VLA= Vertical long axis; 2D= 2-dimensional; 3D= 3- dimensional 436 
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Table 2. Details of individual studies used to derive the grading parameters in this consensus document. 437 
Study 
author 
Subjects 
(M:F) 
Age range, 
years 
Subjects details Country Field 
strength 
Chamber Measurement methods 
Maceira et 
al20 
120 
(60:60) 
10 M and 
10 F in 6 
age deciles 
from 20 to 
80 years 
20-80 
 
Healthy volunteers. Asymptomatic, no 
known cardiovascular risk factors or 
history of cardiac disease. Normal 
physical examination and ECG. Normal 
BNP levels. 
UK 1.5 Tesla Left 
Ventricle 
SSFP cine imaging. Left ventricular short axis stack. 
Papillary muscles included in mass and excluded from volumes.  
Slice thickness of 7mm.  
Basal slices for end-diastole and end-systole 
had at least 50% of blood volume surrounded by myocardium. The 
apical slice defined as last slice showing intracavity blood pool 
(Figure 1) 
Maceira et 
al23 
     Right 
Ventricle 
Included papillary muscles in mass and excluded them from 
volumes.  
Slice thickness of 7mm.  
Maceira et 
al21 
     Left 
atrium 
3-D modelling, including tracking of AV ring. Atrial volumes 
analysed in 2 steps. Endocardial borders included atrial appendage 
included in the volume. Systolic descent and twist of the mitral 
valve was calculated from the tracking of the valve motion on the 
long axis cine to allow for correction for increase in LA volume due 
to AV ring descent. LA diameters and areas were measured at end 
systole. Left atrial appendage included in the atrial volume, but 
pulmonary veins were not.  
Slice thickness of 5mm with no inter-slice gap. 
Maceira et 
al22 
     Right 
atrium 
3-D modelling, including tracking of AV ring and time-volume curve 
analysis. RA maximum volume and maximum diameter measured 
in the 4-chamber and right 2-chamber views. Volume analysis in 2 
steps. 1) Delineation of atrial endocardial border in all cardiac 
phases. 2) Systolic descent and twist of the tricuspid valve 
calculated from tracking valve motion in long axis cines, to correct 
for the increase in atrial volumes due to AV ring descent. Atrial 
appendage included in volumes, vena cava excluded. Diameters 
and areas from 2D images measured in the phase and 
corresponding cines where atrial size and volumes were at a 
maximum. Longitudinal diameter measured from the midpoint of a 
line between the septal and lateral (superior and inferior 
pertaining to the 2-chamber view) insertion of the tricuspid valve 
to the roof of the right atrium. Transverse diameter measured 
perpendicular to the midpoint of the longitudinal diameter.  
Slice thickness of 5mm with no inter-slice gap. 
 22 
Hudsmith 
et al19 
108 
(63:45)  
21-68 Healthy volunteers. No history of 
cardiac disease, hypertension or 
cardiac risk factors and had a normal 
baseline electrocardiogram 
UK 1.5 Tesla Left 
Ventricle 
SSFP cine imaging.  
Papillary muscles were included in the mass and excluded from the 
volumes.  
Slice thickness of 7mm was used for scanning (Figure 1).  
      Right 
Ventricle 
RV volumes below the pulmonary valve. RV volumes were 
excluded if the surrounding muscle was thin and not trabeculated, 
suggestive of right atrium. Papillary muscles were included in the 
mass and excluded from the volume calculation. 
      Left 
atrium 
Left atrial volumes, ejection fraction and stroke volumes using the 
biplane area-length method in the horizontal and vertical long axis. 
Left atrial appendage included in the atrial volume, but the 
pulmonary veins were excluded 
Alfakih et 
al24 
60 (30:30) 20-65 Healthy volunteers. with no history of 
cardiovascular disease or 
hypertension, with a normal blood 
pressure, normal cardiovascular 
examination and normal resting 
electrocardiogram. Subjects with 
arrhythmia, who were pregnant or 
elite athletes were excluded.   
UK 1.5 Tesla Left 
Ventricle 
 
SSFP cine imaging. 
Papillary muscles included in the mass and excluded from the 
volumes (Figure 1).  
Slice thickness of 7mm. 
 
      Right 
ventricle 
Included papillary muscles in the RV volume and excluded them 
from the mass (Figure 1).  
Sievers et 
al28 
70 (38:32) 25-73 Healthy volunteers. No cardiac or 
pulmonary disease and no 
cardiovascular risk factors. 
Germany 1.5 Tesla Right 
atrium 
SSFP cine images. Atrial parameters from both short axis (atrial 
appendage was included in the volume, vena cava excluded, not 
included in this paper) and area length method (right atrial 
volumes and EF were then calculated using the area length 
method for ellipsoid bodies using formula: 8 x (Area1)2 /3π Length, 
included in this paper) from the 4-chamber view (Figure 3). 
Burman et 
al25 
120 
(60:60) 
20-80 Healthy volunteers. Asymptomatic, 
had no known cardiovascular risk 
factors or history of cardiac disease. 
Physical examination was normal and 
the ECG was unremarkable. All brain 
natriuretic peptides (BNP) levels were 
in the normal range. 
UK 1.5 Tesla Aorta SSFP cines images. 
Maximum systolic and end diastolic measurements at 3 levels in 
sagittal and coronal LVOT planes: at level of the aortic annulus, at 
level of the maximum diameter across the sinuses, and at 
sinotubular junction (Figure 4).  
Slice thickness of 7mm. 
Abbreviations: BNP = brain naturetic peptide; ECG = electrocardiogram; EF = ejection fraction; LV = left ventricle; RV = right ventricle; SSFP = steady state free precession; UK = 438 
United Kingdom;  439 
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Table 3 – Left ventricle ranges for adults aged 20-80 years* based on Kawel-Boehm meta-analysis.16 441 
 Women Men Methods 
and 
Reference 
“Opposite” Reference 
range 
Mildly 
abnormal 
Moderately 
abnormal 
Severely 
abnormal 
“Opposite” Reference 
range 
Mildly 
abnormal 
Moderately 
abnormal 
Severely 
abnormal 
20-80 years    
EDV [ml] 
<86 86 - 178 179 - 201 202 - 224 >224 <106 106 - 214 215 - 241 242 - 268 >268 SM 
EDV /BSA 
[ml/m2] 
<56 56 - 96 97 - 106 107 - 116 >116 <57 57 - 105 106 - 117 118 - 129 >129 SM 
ESV [ml] <22 22 - 66 67 - 77 78 - 88 >88 <26 26 - 82 83 - 96 97 - 110 >110 SM 
ESV/BSA 
[ml/m2]# 
<14 14 - 34 35 - 39 40 - 44 >44 <14 14 - 38 39 - 44 45 - 50 >50 SM 
EF [%] >78 57 - 77 41 - 56 30 - 40 <30 >78 57 - 77 41 - 56 30 - 40 <30 SM, EC 
Mass [g] <56 56 - 140 141 - 161 162 - 182 >182 <92 92 - 176 177 - 197 198 - 218 >218 SM 
Mass/BSA 
[g/m2] 
<41 41 - 81 82 - 91 92 - 101 >101 <49 49 - 85 86 - 94 95 - 103 >103 SM 
Abbreviations: BSA = Body surface area; EC = Expert consensus; EDV = End-diastolic volume; EF = Ejection fraction; ESV = End-systolic volume; LV= 442 
Left ventricular; “Opposite” refers to values that outside the normal range but in the opposite direction of typical pathology, e.g. smaller LV end-443 
diastolic volumes or supra-normal LV ejection fraction; SM = Statistical method. 444 
*Combined values from references Alfakih24 (30 Males:30 Females), Hudsmith19 (63 Males:45 Females), Maceira20 (60 Males:60 Females), unless stated 445 
otherwise. 446 
#From references Hudsmith19 (63 Males:45 Females) and Maceira20 (60 Males:60 Females) only. 447 
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Table 4 – Right Ventricle ranges for adults aged 20-68 years* based on Kawel-Boehm meta-analysis.16 451 
 Women Men Methods 
and 
Reference 
“Opposite” Reference 
range 
Mildly 
abnormal 
Moderately 
abnormal 
Severely 
abnormal 
“Opposite” Referenc
e range 
Mildly 
abnormal 
Moderately 
abnormal 
Severely 
abnormal 
20-68 years    
EDV [ml] <77 77-201 202-232 233-263 >263 <118 118-250 251-283 284-316 >316 SM 
EDV /BSA 
[ml/m2] 
<48 48-112 113-128 129-144 >144 <61 61-121 122-136 137-151 >151 SM 
ESV [ml] <24 24-84 85-99 100-114 >114 <41 41-117 118-136 137-155 >155 SM 
ESV/BSA 
[ml/m2]# 
<12 12-52 53-62 63-72 >72 <19 19-59 60-69 70-79 >79 SM 
EF [%] >71 51-71 41-51 30-40 <30 >72 52-72 41-52 30-40 <30 SM, EC 
Mass [g]# <21 21-49 50-56 57-63 >63 <25 25-57 58-65 66-73 >73 SM 
Mass/BSA 
[g/m2]# 
<12 12-28 29-32 33-36 >36 <13 13-29 30-33 34-37 >37 SM 
Abbreviations: BSA = Body surface area; EC = Expert consensus; EDV = End-diastolic volume; EF = Ejection fraction; ESV = End-systolic volume; RV= 452 
right ventricular; “Opposite” refers to values that outside the normal range but in the opposite direction of typical pathology, e.g. smaller LV end-453 
diastolic volumes or supra-normal LV ejection fraction; SM = Statistical method. 454 
*Combined values from references Alfakih24 (30 Males:30 Females), Hudsmith19 (63 Males:45 Females). 455 
#From references Hudsmith (63 Males:45 Females) only. 456 
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Table 5 – Left atrial maximal volume in the adult based on 3D modeling method and left atrial maximal area in the adult for the SSFP technique*.21 459 
 Women Men Methods 
and 
Reference 
“Opposite” Reference 
range 
Mildly 
abnormal 
Moderately 
abnormal 
Severely 
abnormal 
“Opposite” Referenc
e range 
Mildly 
abnormal 
Moderately 
abnormal 
Severely 
abnormal 
20-80 years    
Max. LA 
volume (ml) 
<38 38-98 99-113 114-128 >128 <47 47-107 108-122 123-137 >137 SM 
Max. LA 
volume/ BSA 
(ml/m2) 
<27 27-53 54-60 61-67 >67 <26 26-52 53-59 60-66 >66 SM 
Adults    
Area (cm2) 
4Ch 
<13 13-27 28-31 32-35 >35 <15 15-29 30-33 34-37 >37 SM 
Area/BSA 
(cm2/ m2) 4Ch 
<8.4 8.4-15.6 15.7-17.4 17.5-19.2 >19.2 <7.4 7.4-14.6 14.7-16.4 16.5-18.2 >18.2 SM 
Area (cm2) 
2Ch 
<10 10-28 29-33 34-38 >38 <12 12-30 31-35 36-40 >40 SM 
Area/BSA 
(cm2/ m2) 2Ch 
<6.2 6.2-15.8 15.9-18.2 18.3-20.6 >20.6 <6.2 6.2-15.8 15.9-18.2 18.3-20.6 >20.6 SM 
Area (cm2) 
3Ch 
<10 10-24 25-28 29-31 >31 <12 12-26 27-30 31-33 >33 SM 
Area/BSA 
(cm2/ m2) 3Ch 
<6.4 6.4-13.6 13.7-15.4 15.5-17.2 >17.2 <6.4 6.4-13.6 13.7-15.4 15.5-17.2 >17.2 SM 
Abbreviations: BSA – Body surface area; LA – Left atrium; Max – Maximum; “Opposite” refers to values that outside the normal range but in the 460 
opposite direction of typical pathology; SM = Statistical method; 2Ch = 2 chamber view; 3Ch = 3 chamber view; 4Ch = 4 Chamber view; SSFP= Steady 461 
state free precession. 462 
*From reference according to reference Maceira, 2010 (60 Males:60 Females) only.21 463 
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Table 6 – Right atrial maximal volume and right atrial maximal area in the adult for the SSFP technique based on Sievers28 and Maceira 465 
publications*.22  466 
 Adults 
“Opposite” Reference 
range 
Mildly 
abnormal 
Moderately 
abnormal 
Severely 
abnormal 
Methods 
and 
Reference 
25-73 years   
Max. RA volume 
(ml)* 
<37 37-169 170-202 203-235 >235 SM 
Max. RA 
volume/BSA 
(ml/m2)* 
<18 18-90 91-108 109-126 >126 SM 
20-80 years       
Area (cm2) 4Ch# 
<14 14-30 31-34 35-38 >38 SM 
Area/BSA (cm2/ 
m2) 4Ch# 
<8 8-16 17-18 19-20 >20 SM 
Area (cm2) 2Ch# <14 14-30 31-34 35-38 >38 SM 
Area/BSA (cm2/ 
m2) 2Ch# 
<8 8-16 17-18 19-20 >20 SM 
Abbreviations: BSA = Body surface area; Max = Maximum; Min = Minimum; “Opposite” refers to values that outside the normal range but in the 467 
opposite direction of typical pathology; RA = Right atrium; SM = Statistical method; 2Ch = 2 chamber view; 4Ch = 4 Chamber view; SSFP= Steady state 468 
free precession. 469 
*From reference a Seivers 2007 (38 Males:32 Females) only.28 470 
#From reference Maceira 2013 (60 Males:60 Females) only.22 471 
 472 
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Table 7: Aortic root dimensions reference ranges for based on Burman publication*.25 475 
 Women Men Methods 
and 
Reference 
“Opposite” Reference 
range 
Mildly 
abnormal 
Moderately 
abnormal 
Severely 
abnormal 
“Opposite” Reference 
range 
Mildly 
abnormal 
Moderately 
abnormal 
Severely 
abnormal 
20 – 80 years    
Annulus (s) 
(mm) <16. 16 - 23 24 - 25 26 - 28 >28 <17 17 - 27 28 - 29 30 - 32 >32 
SM 
Annulus (c) 
(mm) <19 19 - 27 28 - 29 30 - 32 >32 <21 21 - 30 31 - 33 34 - 36 >36 
SM 
Aortic sinus(s) 
(mm) <22 22 - 35 36 - 39 40 - 42 >42 <24 24 - 40 41 - 45 46 - 50 >50 
SM 
Aortic sinus(c) 
(mm) <24 24 - 36 37 - 40 41 - 43 >43 <25 25 - 42 43 - 47 48 - 52 >52 
SM 
STJ (s) (mm) <18 18 - 30 31 - 33 34 - 36 >36 <17 17 - 33 34 - 37 38 - 42 >42 SM 
STJ (c) (mm) <18 18 - 28 29 - 31 32 - 34 >34 <18 18 - 32 33 - 36 37 - 40 >40 SM 
Abbreviations: c = Coronal left ventricular outflow plane; F = Female; M = Male; STJ = Sino tubular junction; s = Sagittal left ventricular outflow plane; 476 
SM = Statistical method 477 
*From reference Burman 2008 (60 Males:60 Females) only.25 478 
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 480 
Figure 1: Short axis slices including left ventricular endocardial and epicardial contours and right 481 
ventricular endocardial contours. The 4 and 2 chamber views show the full coverage of the left 482 
and right ventricles required for analysis.  483 
 484 
 485 
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 486 
Figure 2: Left atrial contours for area assessment in 4 and 2 chambers during atrial end diastole, 487 
measures just before the mitral valve opening for maximum LA volume.  488 
 489 
 490 
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 492 
Figure 3: Right atrial contour for area length measurement during atrial end diastole for 493 
maximal RA volume.  494 
 495 
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 497 
Figure 4: Oblique sagittal# (A, B) and oblique coronal* (C, D) left ventricular outflow views 498 
showing the common aortic root measurements. Typically, annulus measured during systole and 499 
sinuses of Valsalva and sino-tubular junction measured in diastole. 11,29 500 
 501 
*Oblique sagittal images were obtained by aligning orthogonal to the coronal scouts in the axis of 502 
the left ventricular outflow tract and proximal ascending aorta.   503 
#Oblique coronal acquisitions were then located orthogonal to the oblique sagittal cine, aligned 504 
with the axis of the left ventricular outflow tract.25 505 
 506 
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